PALATIN TECHNOLOGIES, INC. Basic Shares Outstanding (Weighted Average)
PALATIN TECHNOLOGIES, INC. (PTN) reported Basic Shares Outstanding (Weighted Average) of 3.91 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-05-13
- PALATIN TECHNOLOGIES, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 3.91M shares, a 642.46% increase year-over-year.
- PALATIN TECHNOLOGIES, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 2.54M shares, a 515.37% increase year-over-year.
- PALATIN TECHNOLOGIES, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 971.65K shares, a 144.80% increase year-over-year.
- PALATIN TECHNOLOGIES, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-03-31 was 526.89K shares.
- PALATIN TECHNOLOGIES, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 14.70M shares, a 34.96% increase from fiscal 2023.
- PALATIN TECHNOLOGIES, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 10.89M shares.
- PALATIN TECHNOLOGIES, INC. weighted average number of shares outstanding, basic for fiscal 2020 was 234.68M shares, a 13.01% increase from fiscal 2019.
- PALATIN TECHNOLOGIES, INC. weighted average number of shares outstanding, basic for fiscal 2019 was 207.67M shares, a 4.83% increase from fiscal 2018.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | 3.91M shares 10-Q · filed 2026-05-13 | 3.23M shares derived: average of 2 quarters · filed 2026-05-13 | 2.46M shares 10-Q · filed 2026-05-13 | ||||
| 2025-12-31 | 2.54M shares 10-Q · filed 2026-02-17 | 1.76M shares 10-Q · filed 2026-02-17 | |||||
| 2025-09-30 | 971.65K shares 10-Q · filed 2025-11-14 | ||||||
| 2025-03-31 | 526.89K shares 10-Q · filed 2026-05-13 | 469.79K shares derived: average of 2 quarters · filed 2026-05-13 | 444.90K shares 10-Q · filed 2026-05-13 | ||||
| 2024-12-31 | 412.70K shares 10-Q · filed 2026-02-17 | 20.63M shares 10-Q · filed 2025-02-13 | 404.80K shares 10-Q · filed 2026-02-17 | 20.24M shares 10-Q · filed 2025-02-13 | |||
| 2024-09-30 | 396.91K shares 10-Q · filed 2025-11-14 | 19.85M shares 10-Q · filed 2024-11-14 | |||||
| 2024-06-30 | 14.70M shares 10-K · filed 2024-09-30 | ||||||
| 2023-12-31 | 14.10M shares 10-Q · filed 2025-02-13 | 13.13M shares 10-Q · filed 2025-02-13 | |||||
| 2023-09-30 | 12.17M shares 10-Q · filed 2024-11-14 | ||||||
| 2023-06-30 | 10.89M shares 10-K · filed 2024-09-30 | ||||||
| 2020-06-30 | 235.39M shares 10-K · filed 2020-09-25 | 235.36M shares derived: average of 2 quarters · filed 2020-09-25 | 235.21M shares derived: average of 3 quarters · filed 2020-09-25 | 234.68M shares 10-K · filed 2020-09-25 | |||
| 2020-03-31 | 235.32M shares 10-K · filed 2020-09-25 | 235.12M shares derived: average of 2 quarters · filed 2020-09-25 | 234.45M shares derived: average of 3 quarters · filed 2020-09-25 | 228.90M shares derived: average of 4 quarters · filed 2020-09-25 | |||
| 2019-12-31 | 234.92M shares 10-K · filed 2020-09-25 | 234.02M shares derived: average of 2 quarters · filed 2020-09-25 | 226.76M shares derived: average of 3 quarters · filed 2020-09-25 | 221.83M shares derived: average of 4 quarters · filed 2020-09-25 | |||
| 2019-09-30 | 233.11M shares 10-K · filed 2020-09-25 | 222.68M shares derived: average of 2 quarters · filed 2020-09-25 | 217.46M shares derived: average of 3 quarters · filed 2020-09-25 | 214.72M shares derived: average of 4 quarters · filed 2020-09-25 | |||
| 2019-06-30 | 212.25M shares 10-K · filed 2020-09-25 | 209.63M shares derived: average of 2 quarters · filed 2020-09-25 | 208.59M shares derived: average of 3 quarters · filed 2020-09-25 | 207.67M shares 10-K · filed 2020-09-25 | |||
| 2019-03-31 | 207.02M shares 10-K · filed 2020-09-25 | 206.75M shares derived: average of 2 quarters · filed 2020-09-25 | 206.15M shares 10-Q · filed 2019-05-09 | 204.77M shares derived: average of 4 quarters · filed 2020-09-25 | |||
| 2018-12-31 | 206.49M shares 10-K · filed 2020-09-25 | 205.72M shares 10-Q · filed 2019-02-11 | 204.03M shares derived: average of 3 quarters · filed 2020-09-25 | 202.39M shares derived: average of 4 quarters · filed 2020-09-25 | |||
| 2018-09-30 | 205.01M shares 10-K · filed 2020-09-25 | 202.80M shares derived: average of 2 quarters · filed 2020-09-25 | 201.03M shares derived: average of 3 quarters · filed 2020-09-25 | 200.08M shares derived: average of 4 quarters · filed 2020-09-25 | |||
| 2018-06-30 | 200.58M shares 10-K · filed 2019-09-12 | 199.03M shares derived: average of 2 quarters · filed 2019-09-12 | 198.44M shares derived: average of 3 quarters · filed 2019-09-12 | 198.10M shares 10-K · filed 2020-09-25 | |||
| 2018-03-31 | 197.49M shares 10-K · filed 2019-09-12 | 197.36M shares derived: average of 2 quarters · filed 2019-09-12 | 197.28M shares 10-Q · filed 2019-05-09 | 197.18M shares derived: average of 4 quarters · filed 2019-09-12 | |||
| 2017-12-31 | 197.24M shares 10-K · filed 2019-09-12 | 197.18M shares 10-Q · filed 2019-02-11 | 197.07M shares derived: average of 3 quarters · filed 2019-09-12 | 196.95M shares derived: average of 4 quarters · filed 2019-09-12 | |||
| 2017-09-30 | 197.11M shares 10-K · filed 2019-09-12 | 196.99M shares derived: average of 2 quarters · filed 2019-09-12 | 196.86M shares derived: average of 3 quarters · filed 2019-09-12 | 192.09M shares derived: average of 4 quarters · filed 2019-09-12 | |||
| 2017-06-30 | 196.87M shares 10-K · filed 2018-09-13 | 196.73M shares derived: average of 2 quarters · filed 2018-09-13 | 190.42M shares derived: average of 3 quarters · filed 2018-09-13 | 198.10M shares 10-K · filed 2020-09-25 | 184.09M shares 10-K · filed 2018-09-13 | ||
| 2017-03-31 | 196.58M shares 10-K · filed 2018-09-13 | 187.19M shares derived: average of 2 quarters · filed 2018-09-13 | 179.84M shares 10-Q · filed 2018-05-14 | ||||
| 2016-12-31 | 177.80M shares 10-K · filed 2018-09-13 | 171.82M shares 10-Q · filed 2018-02-12 | |||||
| 2016-09-30 | 165.85M shares 10-K · filed 2018-09-13 | ||||||
| 2016-06-30 | 156.55M shares 10-K · filed 2018-09-13 | ||||||
| 2015-12-31 | 156.36M shares 10-Q · filed 2016-02-12 | 156.27M shares 10-Q · filed 2016-02-12 | 148.97M shares derived: average of 3 quarters · filed 2016-09-19 | 145.23M shares derived: average of 4 quarters · filed 2016-09-19 | |||
| 2015-09-30 | 156.36M shares 10-Q · filed 2015-11-12 | 145.28M shares derived: average of 2 quarters · filed 2016-09-19 | 141.52M shares derived: average of 3 quarters · filed 2016-09-19 | 133.47M shares derived: average of 4 quarters · filed 2016-09-19 | |||
| 2015-06-30 | 134.21M shares 10-K · filed 2016-09-19 | 134.11M shares derived: average of 2 quarters · filed 2016-09-19 | 125.84M shares derived: average of 3 quarters · filed 2016-09-19 | 121.12M shares derived: average of 4 quarters · filed 2016-09-19 | |||
| 2015-03-31 | 134.01M shares 10-K · filed 2016-09-19 | 121.66M shares derived: average of 2 quarters · filed 2016-09-19 | 116.76M shares derived: average of 3 quarters · filed 2016-09-19 | ||||
| 2014-12-31 | 109.31M shares 10-K · filed 2016-09-19 | 108.13M shares 10-Q · filed 2016-02-12 | |||||
| 2014-09-30 | 106.95M shares 10-K · filed 2016-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |